Krystal Biotech, Inc.KRYSNASDAQ
LOADING
|||
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
15.38%
↓ 81% below average
Average (8y)
80.38%
Historical baseline
Range
High:332.93%
Low:0.00%
Volatility
414.2%
High variability
| Period | Value |
|---|---|
| 2024 | 15.38% |
| 2023 | 9.35% |
| 2022 | 52.28% |
| 2021 | 55.46% |
| 2020 | 14.86% |
| 2019 | 101.21% |
| 2018 | 141.93% |
| 2017 | 332.93% |
| 2016 | 0.00% |